EditorsAbout the SiteComes vs. MicrosoftUsing This Web SiteSite ArchivesCredibility IndexOOXMLOpenDocumentPatentsNovellNews DigestSite NewsRSS

06.07.10

The Gates Foundation-Connected GlaxoSmithKline Indirectly Paid Scientists to Exaggerate Vaccine Needs

Posted in Bill Gates, Intellectual Monopoly, Patents at 5:15 am by Dr. Roy Schestowitz

GlaxoSmithKline logo

Summary: The philanthrocapitalist establishment whose Head of Global Health comes from GlaxoSmithKline has its work put to great scrutiny

THE Gates Foundation does not get much of a break because more and more people are beginning to understand its interests. It’s more complex than just “charity” as profit is being made without the foundation ever been taxed like a normal investor.

Today we turn our sceptical eye to the issue of patents and how the Gates Foundation promotes them. There is no question about the fact that Africa suffers from deadly diseases and Gates’ endeavours there are mostly commendable [1, 2]. It is a short-term solution which probably works well for both sides.

“The Gates Foundation acts as somewhat of a PR shim that intervenes where patents interfere/intersect with human toll.”What ought to be better understood is Bill Gates’ close relationship and interpersonal ties with the world’s largest pharmaceutical companies, which even work well inside the Gates Foundation (holding key positions). The Gates Foundation acts as somewhat of a PR shim that intervenes where patents interfere/intersect with human toll. It’s a marriage of convenience because the price of life is the route to big profits.

The following new report from The Guardian reveals that flu experts were indirectly being paid by pharmaceutical giants in order to overplay the risk of swine flu and thus increase sales of vaccines. GlaxoSmithKline (GSK) is mentioned among the culprits. [via Richard stallman]

Report condemns swine flu experts’ ties to big pharma

Scientists who drew up the key World Health Organisation guidelines advising governments to stockpile drugs in the event of a flu pandemic had previously been paid by drug companies which stood to profit, according to a report out today.

An investigation by the British Medical Journal and the Bureau of Investigative Journalism, the not-for-profit reporting unit, shows that WHO guidance issued in 2004 was authored by three scientists who had previously received payment for other work from Roche, which makes Tamiflu, and GlaxoSmithKline (GSK), manufacturer of Relenza.

City analysts say that pharmaceutical companies banked more than $7bn (£4.8bn) as governments stockpiled drugs. The issue of transparency has risen to the forefront of public health debate after dramatic predictions last year about a swine flu pandemic did not come true.

GSK was mentioned by us earlier today. We promised to revisit the subject because according to Portfolio.com, not only does the Gates Foundation have staff from GSK but it also has power over GSK:

The Bill & Melinda Gates Foundation was a driving force behind GlaxoSmithKline Plc’s decision to share propietary drug research for fighting malaria, the Puget Sound Business Journal reports.

That’s the same GSK which corrupted science in order to increase sales. That’s the same GSK which brought to the Gates Foundation its Head of Global Health, who bullies researchers. Gates Keepers writes about those patented drugs which the Gates Foundation is promoting:

Read this carefully: “so that all the people who are smart about the disease are to some degree on the same side, working together.” Here is a fatal flaw. Gates thinks that you can define “all the people who are smart about the disease” and invite them to work together. He and his staff wouldn’t know how to begin to find “all the people”. They are elite technocrats. How many people LIVING with the disease are working together on his elite panels?

This whole “parenthood” role which the Gates Foundation has been taking for years is sometimes just a tad insulting (patronising even) and it marginalises opposing/alternative points of view. Researchers often complain about that. Here is someone who is challenging their priorities:

Gates really, really likes the idea of using vertical funds to tackle (and eliminated) diseases one by one, rather than taking a more gradual, measured approach. Why do the big philanthropists (Gates, and by proxy, Buffet) prefer to take such a direct approach, circumventing governments?

The easiest explanation is through personality or experience: Gates is an entrepreneur, used to getting smart people in a room together to solve problems; private solutions for important problems. Governments have, if anything, been a source of irritation for him, lobbing the occasional anti-trust action at Microsoft.

[...]

I think it’s probably unrealistic to expect the Gates Foundation to start up a health SWAp anytime soon – the same factors that led to its creation will always drive it to tackle problems the way it does. What we should hope (and push) for is a commitment to “do no harm.” This means reverting to practices that do not distort health objectives on the ground (i.e. internal brain drain of qualified health staff, shifting the debate away from enforcing health systems to tackling single diseases). Working on vaccines, either through direct funding or advance market commitments, is a an example of high risk but less distortionary practice. The huge sums of money the Foundation juggles could also be used to create incentives for more general research into fighting tropical maladies, and then subsequently subsidise the price for needy countries.

Here is another new example from NYTimes.com. It’s very relevant to the above example.

“iBio and Fraunhofer USA Center for Molecular Biotechnology Enter Agreement to Provide Global Access for Bill & Melinda Gates Foundation Vaccines,” says the title of this new press release.

iBio, Inc. and the Fraunhofer USA Center for Molecular Biotechnology (CMB) announced today an agreement which provides a license of iBio’s proprietary technology to CMB for the development and manufacture of Global Health Vaccines for, and financed by, the Bill & Melinda Gates Foundation.

To avoid misunderstandings, the problem here is not vaccinations. Immunology and drugs are important and often vital for the saving of lives, but the economics here are a tricky operation that leaves the public out in the dark. The drugs industry is not just another industry like IT. The drug industry is massive and that’s where the big money is. Gates has investments in this industry, so it’s in his interest to promote it. Another related area is biotechnology, where Monsanto got itself a nice monopoly on the food chain. “Bill Gates reveals support for GMO eg,” says this headline from last year (one that we’ve just found and missed at the time, even though we already quite knowingly stated the facts [1, 2, 3, 4, 5, 6, 7, 8]).

As it has come to dominate the agenda for reshaping African agriculture over the years, the Bill and Melinda Gates Foundation has been very careful not to associate itself too closely with patent-protected biotechnology as a panacea for African farmers.

True, the foundation named 25-year Monsanto veteran Rob Horsch to the position of “senior program officer, focusing on improving crop yields in sub-Saharan Africa.”

Yet its flagship program for African ag, the Alliance for a Green Revolution in Africa (AGRA), explicitly distances itself from GMOs. “AGRA does not fund the development of GMOs,” the organization’s Web site states.

But AGRA — co-funded by the Rockefeller Foundation, proud sponsor of the original Green Revolution — is just part of what Gates does around African ag. What precisely is the foundation getting up to over there? Is it pushing GMOs on African smallholder farms?

Earlier on we wrote about GSK inside the Gates Foundation (Head of Global Health), but what many people overlook is that fact that there are Monsanto employees inside the Gates Foundation. They use the Gates Foundation as a seemingly ‘charitable’ lobby vehicle through which to advance the companies’ objectives, often at the expense of the public (which pays government tax to be funneled into patents on drugs for the developing world). It’s a simple matter of economics, creating scarcity with patents while profiting from massive tax-free investments.

There is another couple of new articles worth paying attention to:

Critics castigate Gastes Foundation on policy demands; India launches native H1N1 vaccines;

[...]

While the Gates Foundation has been widely lauded for its work on a wide range of initiatives, including financing research on new vaccines to guard against common killers in developing nations, some critics have emerged to caution against the foundation’s demands to “toe the line” on its position in policy debates.

Watch another man from the Gates Foundation offering “farming aid” (possibly a veiled reference to GMO):

Prior to joining the Obama Administration, Shah served as director of Agricultural Development in the Global Development Program at the Bill and Melinda Gates Foundation. In his seven years with the Gates Foundation, Shah served as the Foundation’s director of Strategic Opportunities and as deputy director of policy and finance for the Global Health Program.

They are getting increasingly connected to politics. Last week in The Times of India:

Obama appoints Indian-American to head U.S National Science Foundation

[...]

Clinton has Rajiv Shah, a former Gates Foundation executive and health expert, heading the USAID.

Clinton is connected to Bill Gates in ways that we explained before. When it comes to the Gates Foundation, former staff is often pursuing similar agendas after departure. To quote this new press release:

Academic Pharmacy Continues to Expand its Horizons at 2010 AACP Annual Meeting

[...]

He was the first business executive to serve as a public school superintendent and was the first executive director for the Bill & Melinda Gates Foundation.

This probably brings us to the subject of our next post, which says more about Gates Foundation influence on public schools [1, 2, 3, 4, 5].

Share this post: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Reddit
  • co.mments
  • DZone
  • email
  • Google Bookmarks
  • LinkedIn
  • NewsVine
  • Print
  • Technorati
  • TwitThis
  • Facebook

If you liked this post, consider subscribing to the RSS feed or join us now at the IRC channels.

Pages that cross-reference this one

What Else is New


  1. The Crook Goes to Brussels to Lie About the Unitary Patent (UPC)

    The person who spent years lying about the UPC and severely attacking critics (usually by blatantly lying about them) goes to Brussels for another nose extension



  2. The EPO's HR Roadmap Retrospective

    A look back at the terrible ‘accomplishments’ of the Jesper Kongstad-led Administrative Council, which still issues hogwash and face-saving lies, as one might expect from a protector of Battistelli that lies to national representatives and buries inconvenient topics



  3. Links 26/3/2017: Debian Project Leader Elections, SecureDrop and Alexandre Oliva FSF Winners

    Links for the day



  4. His Master's Voice, Jesper Kongstad, Blocks Discussion of Investigative and Disciplinary Procedures at the EPO

    The Chairman of the Administrative Council of the European Patent Organisation is actively preventing not just the dismissal of Battistelli but also discussion of Battistelli's abuses



  5. Heiko Maas and the State of Germany Viewed as Increasingly Complicit in EPO Scandals and Toxic UPC Agenda

    It is becoming hard if not impossible to interpret silence and inaction from Maas as a form of endorsement for everything the EPO has been doing, with the German delegates displaying more of that apathy which in itself constitutes a form of complicity



  6. With IP Kat Coverage of EPO Scandals Coming to an End (Officially), Techrights and The Register Remain to Cover New Developments

    One final post about the end of Merpel’s EPO coverage, which is unfortunate but understandable given the EPO’s track record attacking the media, including blogs like IP Kat, sites of patent stakeholders, and even so-called media partners



  7. Everyone, Including Patent Law Firms, Will Suffer From the Demise of the EPO

    Concerns about quality of patents granted by the EPO (EPs) are publicly raised by industry/EPO insiders, albeit in an anonymous fashion



  8. Yes, Battistelli's Ban on EPO Strikes (or Severe Limitation Thereof) is a Violation of Human Rights

    Battistelli has curtailed even the right to strike, yet anonymous cowards attempt to blame the staff (as in patent examiners) for not going out of their way to engage in 'unauthorised' strikes (entailing dismissal)



  9. Even the EPO's Administrative Council No Longer Trusts Its Chairman, Battistelli's 'Chinchilla' Jesper Kongstad

    Kongstad's protection of Battistelli, whom he is supposed to oversee, stretches to the point where national representatives (delegates) are being misinformed



  10. Thanks to Merpel, the World Knows EPO Scandals a Lot Better, But It's a Shame That IP Kat Helped UPC

    A look back at Merpel's final post about EPO scandals and the looming threat of the UPC, which UPC opportunists such as Bristows LLP still try hard to make a reality, exploiting bogus (hastily-granted) patents for endless litigation all around Europe



  11. EPO Critics Threatened by Self-Censorship, Comment Censorship, and a Growing Threat to Anonymity

    Putting in perspective the campaign for justice at the EPO, which to a large degree relies on whistleblowers and thus depends a great deal on freedom of the press, freedom of speech, and anonymity



  12. Links 25/3/2017: Maru OS 0.4, C++17 Complete

    Links for the day



  13. Judge and Justice Bashing in the United States, EPC Bashing at the EPO

    Enforcement of the law based on constitutional grounds and based on the European Patent Convention (EPC) in an age of retribution and insults -- sometimes even libel -- against judges



  14. Looking for EPO Nepotism? Forget About Jouve and Look Closely at Europatis Instead.

    Debates about the contract of Jouve with the EPO overlook the elephants in the room, which include companies that are established and run by former EPO chiefs and enjoy a relationship with the EPO



  15. Depressing EPO News: Attacks on Staff, Attacks on Life, Brain Drain, Patents on Life, Patent Trolls Come to Germany, and Spain Being Misled

    A roundup of the latest developments at the EPO combined with feedback from insiders, who are not tolerating their misguided and increasingly abusive management



  16. It Certainly Looks Like Microsoft is Already Siccing Its Patent Trolls, Including Intellectual Ventures, on Companies That Use Linux (Until They Pay 'Protection' Money)

    News about Intellectual Ventures and Finjan Holdings (Microsoft-funded patent trolls) reinforces our allegations -- not mere suspicions anymore -- that Microsoft would 'punish' companies that are not paying subscription fees (hosting) or royalties (patent tax) to Microsoft and are thus in some sense 'indebted' to Microsoft



  17. Links 24/3/2017: Microsoft Aggression, Eudyptula Challenge Status Report

    Links for the day



  18. Bernhard Rapkay, Former MEP and Rapporteur on Unitary Patent, Shoots Down UPC Hopes While UPC Hopefuls Recognise That Spain Isn't Interested Either

    Germany, the UK and Spain remain massive barriers to the UPC -- all this in spite of misleading reports and fake news which attempted to make politicians believe otherwise (for political leverage, by means of dirty lobbying contingent upon misinformation)



  19. Links 23/3/2017: Qt 5.9 Beta, Gluster Storage 3.2

    Links for the day



  20. The Administrative Council of the European Patent Organisation Has Just Buried an Innocent Judge That Battistelli Does Not Like

    An innocent judge (never proven guilty of anything, only publicly defamed with help from Team Battistelli and dubious 'intelligence' gathering) is one of the forgotten casualties of the latest meeting of the Administrative Council (AC), which has become growingly complicit rather than a mere bystander at a 'crime' scene



  21. Nepotism at the European Patent Office and Suspicious Absence of Tenders for Big Projects

    Carte blanche is a French term which now perfectly describes the symptoms encountered in the European Patent Office, more so once led by a lot of French people (Battistelli and his friends)



  22. “Terror” Patent Office Bemoans Terror, Spreads Lies

    Response to some of the latest utterances from the European Patent Office, where patently untruthful claims have rapidly become the norm



  23. China Seems to be Using Patents to Push Foreign Companies Out of China, in the Same Way It Infamously Uses Censorship

    Chinese patent policies are harming competition from abroad, e.g. Japan and the US, and US patent policy is being shaped by its higher courts, albeit not yet effectively combating the element that's destroying productive companies (besieged by patent trolls)



  24. 22,000 Blog Posts

    A special number is reached again, marking another milestone for the site



  25. The EPO is Lying to Its Own Staff About ILO and Endless (Over 2 Years) EPO Mistrials

    The creative writing skills of some spinners who work for Battistelli would have staff believe that all is fine and dandy at the EPO and ILO is dealing effectively with staff complaints about the EPO (even if several years too late)



  26. EPO’s Georg Weber Continues Horrifying Trend of EPO Promoting Software Patents in Defiance of Directive, EPC, and Common Sense

    The EPO's promotion of software patents, even out in the open, is an insult to the notion that the EPO is adhering to or is bound by the rules upon which it maintains its conditional monopoly



  27. Protectionism v Sharing: How the US Supreme Court Decides Patent Cases

    As the US Supreme Court (SCOTUS) starts delivering some decisions we take stock of what's to come regarding patents



  28. Links 22/3/2017: GNOME 3.24, Wine-Staging 2.4 Released

    Links for the day



  29. The Battistelli Regime, With Its Endless Scandals, Threatens to Crash the Unitary Patent (UPC), Stakeholders Concerned

    The disdain and the growing impatience have become a huge liability not just to Battistelli but to the European Patent Office (EPO) as a whole



  30. The Photos the EPO Absolutely Doesn't Want the Public to See: Battistelli is Building a Palace Using Stakeholders' Money

    The Office is scrambling to hide evidence of its out-of-control spendings, which will leave the EPO out of money when the backlog is eliminated by many erroneous grants (or rejections)


CoPilotCo

RSS 64x64RSS Feed: subscribe to the RSS feed for regular updates

Home iconSite Wiki: You can improve this site by helping the extension of the site's content

Home iconSite Home: Background about the site and some key features in the front page

Chat iconIRC Channel: Come and chat with us in real time

CoPilotCo

Recent Posts